Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Supernus Pharmaceuticals Inc
About SUPN
Supernus Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Its neuroscience portfolio includes treatments for attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson's Disease (PD) patients receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea. Its products include Qelbree, GOCOVRI, APOKYN, Trokendi XR, Oxtellar XR, ZURZUVAE, ONAPGO, XADAGO, and MYOBLOC. Qelbree is a non-stimulant product indicated for the treatment of ADHD in adults and pediatric patients six years and older. GOCOVRI extended-release capsules are medicine indicated for the treatment of dyskinesia in patients with PD receiving levodopa-based therapy. It is also involved in developing product candidates in neurology and psychiatry, including SPN-817 (huperzine A), SPN-820 (NV-5138), and SPN-443.
Find out what a historical investment in Supernus Pharmaceuticals Inc would be worth today using our SUPN stock calculator.
Market Capitalisation
$2.83B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
529.46K
High today
$49.66
Low today
$47.98
Open price
$48.68
52-week high
$59.68
52-week low
$30.83
Ready to start your investing journey with Stake?
Open an accountHow do I buy SUPN shares in Australia?
Buying SUPN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Supernus Pharmaceuticals Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in SUPN
What is the ticker symbol of Supernus Pharmaceuticals Inc?
The ticker symbol for Supernus Pharmaceuticals Inc is SUPN.
How much is one share of SUPN?
One share of SUPN is valued at $49.36 as of 21 May 2026.
What is the market capitalisation of Supernus Pharmaceuticals Inc SUPN?
As of 21 May 2026 Supernus Pharmaceuticals Inc has a market cap of $2.83B.
What is the 52-week high for Supernus Pharmaceuticals Inc stock?
The Supernus Pharmaceuticals Inc 52-week high stock price is $59.68.
What is the 52-week low for Supernus Pharmaceuticals Inc stock?
The Supernus Pharmaceuticals Inc 52-week low stock price is $30.83.
Can I buy SUPN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy SUPN shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SUPN on Stake
- Buy SUPN from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of SUPN from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
SUPN related stocks